Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease [Phase 1]
Clinical trial update outlining a Phase 1 study of Adrixetinib (Q702) in adults with active chronic graft-versus-host disease, currently rec…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Optimizing PTCy Dose and Timing [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study aiming to optimize the dose and timing of post-transplant cyclophosphamide t…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial is evaluating ibrutinib for prevention of chronic graft-versus-host disease in patients receiving donor stem cell t…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT [Phase 3]
Phase 3 clinical trial evaluating whether different stem cell infusion times affect the incidence of acute graft-versus-host disease after u…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Dynamic of Immunocompetent Populations in Patients Treated With Extracorporeal Photopheresis in Chronic Graft Versus Host Disease
This clinical trial update indicates that NCT03438643, studying immunocompetent populations treated with extracorporeal photopheresis for ch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host [Phase 2]
A Phase 2 clinical trial assessing the efficacy and safety of nilotinib in patients with chronic graft-versus-host disease.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL [Phase 2, Phase 3]
This study outlines a framework to optimize, refine, and unify management of hematopoietic stem cell transplantation in pediatric acute lymp…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: UVB Phototherapy Treatment of Oral Chronic GVHD [Phase 2]
Phase 2 trial evaluating UVB phototherapy for oral chronic graft-versus-host disease has been terminated.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Electrostimulation Study for Ocular Graft vs. Host Disease [NA]
Clinical trial update describing an electrostimulation study for chronic ocular graft-versus-host disease. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD) [Phase 1, Phase 2]
This is a clinical trial update on first-line jaktinib for acute graft-versus-host disease. The study is in Phase 1/Phase 2 and currently re…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) [Phase 2]
A Phase 2 study evaluating Vimseltinib in adults with active chronic graft-versus-host disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial registration to optimize graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation. T…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib [Phase 2]
This clinical trial update describes a Phase 2 rollover study of Itacitinib to provide continued treatment for participants previously enrol…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: The Oral cGVHD as a Predictive Factor of Graft Versus Leukaemia Effect in Patients Who Received an Allograft
This clinical trial update reports on whether oral chronic graft-versus-host disease can predict the graft-versus-leukemia effect in allogen…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Detection of Graft Versus Host Disease With [18F]F-AraG [Phase 1]
Phase 1 trial evaluating the PET imaging agent [18F]F-AraG for detecting graft-versus-host disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) [Phase 1, Phase 2]
A Phase 1/Phase 2 study of TQ05105 tablets for glucocorticoid-refractory acute graft-versus-host disease has completed.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease [Phase 3]
Clinical trial update indicating a Phase 3 study evaluating Rovadicitinib for moderate-to-severe chronic graft-versus-host disease, with rec…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias [Phase 2]
A Phase 2 trial of fostamatinib for immune-mediated anemia, immune-mediated thrombocytopenia, and chronic graft-versus-host disease after he…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD [Phase 2]
Phase 2 clinical trial of CYP-001 in combination with corticosteroids for adults with high-risk acute graft-versus-host disease is currently…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease [Phase 1, Phase 2]
Phase 1/2 study of TQ05105 for chronic graft-versus-host disease, with the trial currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Fecal Microbiota Transplantation in aGvHD After ASCT [Phase 3]
This Phase 3 clinical trial, sponsored by the Medical University of Graz, is evaluating fecal microbiota transplantation for acute graft-ver…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of ruxolitinib in Chinese participants with corticosteroid-refractory chronic g…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease [Phase 4]
Phase 4 clinical trial assessing the efficacy and safety of ruxolitinib in adults with grade II-IV steroid-refractory acute graft-versus-hos…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease [Phase 2]
Phase 2 clinical trial evaluating safety, PK/PD, dosing, and efficacy of RLS-0071 for hospitalized patients with steroid-refractory acute gr…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating BPC2001 for preventing acute graft-versus-host disease after haploidentical stem cell transplantation is…